Pharmacokinetic profile and in vitro selective cyclooxygenase-2 inhibition by nimesulide in the dog.
about
Effects of the cyclooxygenase-2 inhibitor nimesulide on cerebral infarction and neurological deficits induced by permanent middle cerebral artery occlusion in the ratPrinciples of pharmacodynamics and their applications in veterinary pharmacology.A pharmacokinetic/pharmacodynamic approach vs. a dose titration for the determination of a dosage regimen: the case of nimesulide, a Cox-2 selective nonsteroidal anti-inflammatory drug in the dog.Dual, but not selective, COX-1 and COX-2 inhibitors, attenuate acetic acid-evoked bladder irritation in the anaesthetised female cat.Pharmacology of drugs used to treat osteoarthritis in veterinary practice.Pharmacodynamics and pharmacokinetics of nonsteroidal anti-inflammatory drugs in species of veterinary interest.PK-PD integration and PK-PD modelling of nonsteroidal anti-inflammatory drugs: principles and applications in veterinary pharmacology.Practical approaches to adverse outcome pathway development and weight-of-evidence evaluation as illustrated by ecotoxicological case studies.Pharmacokinetic/pharmacodynamic integration in drug development and dosage-regimen optimization for veterinary medicine.Pharmacokinetics and bioavailability of nimesulide in goats.Preparation and characterization of nimesulide containing nanocrystal formulations.Nimesulide, a cyclooxygenase-2 preferential inhibitor, impairs renal function in the newborn rabbit.Enantioselective pharmacokinetics and cyclo-oxygenase inhibition of carprofen and carprofen enantiomers in sheep.Effects of a cyclooxygenase-2 preferential inhibitor in young healthy dogs exposed to air pollution: a pilot study.Effects of cyclooxygenase inhibition on canine coronary artery blood flow and thrombosis.Evaluation of the dose-response relationship of oral robenacoxib in urate crystal-induced acute stifle synovitis in dogs.
P2860
Q24796019-9BF3E903-FF58-4C9B-AE00-836407DA294AQ34376757-8AC572E3-76C3-48EA-8631-FFD415600947Q34515131-75F7154D-60CA-4067-9675-C2DE3C912606Q35100868-93A88BDD-3CE1-4EC7-A377-5993DDC91DDBQ35702313-B6076AB2-0860-424A-93F0-F45D198F41E2Q35985424-26129C25-648C-4754-87EE-DFE3AEE44075Q35985430-D428DBC1-D9C8-4D07-8D14-CB90614B2BF2Q38960807-309128E0-ECC4-4E03-A856-C38A0E608134Q42104275-897587FA-EC7F-415A-9C0A-AA2E3C73D417Q42614057-194C0C65-1045-449B-95DD-17BE990EB57AQ43772045-C44084AA-533F-4459-A4BC-64D748B554F9Q44647112-90C2CFAA-1837-4B57-BC49-ACCCABE8B23CQ44665768-43ECB17D-4AC1-44BD-B2FC-9D1E9AF62240Q45917440-A38271D1-3F22-4A30-A393-4D1EFE120DC6Q46962257-62A67D2F-1C05-4DC9-87B4-CBDA6E68587DQ53044021-0A3E0C5B-DF46-44C2-B73B-3C19D855DC76
P2860
Pharmacokinetic profile and in vitro selective cyclooxygenase-2 inhibition by nimesulide in the dog.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Pharmacokinetic profile and in ...... tion by nimesulide in the dog.
@en
Pharmacokinetic profile and in ...... tion by nimesulide in the dog.
@nl
type
label
Pharmacokinetic profile and in ...... tion by nimesulide in the dog.
@en
Pharmacokinetic profile and in ...... tion by nimesulide in the dog.
@nl
prefLabel
Pharmacokinetic profile and in ...... tion by nimesulide in the dog.
@en
Pharmacokinetic profile and in ...... tion by nimesulide in the dog.
@nl
P2093
P2860
P1476
Pharmacokinetic profile and in ...... tion by nimesulide in the dog.
@en
P2093
P2860
P356
10.1046/J.1365-2885.2001.00303.X
P577
2001-02-01T00:00:00Z